Women are missing from medicines development: EMA’s roadmap for change

RegulatoryPositive

AI Analysis

Summary

The EMA announced plans to develop a regulatory roadmap by end of 2026 to improve consideration of women's health in medicines development and regulation. The initiative follows a multistakeholder workshop bringing together over 100 voices from regulators, patients, and healthcare stakeholders.

Outcome Details

EMA to develop regulatory roadmap for women's health in medicines development by end of 2026

Importance:5/10

Sentiment:

0.60

women's healthregulatory roadmapmedicines developmentEMA

Related Companies

$ISCO $HR $NHPAP $HIT

Read the original article

Published by EMA News on September 30, 2026 9:32 AM

Read Original